Fig 1: Damaged mitochondrial DNA activates ZBP1/TBK1/IRF3 signaling pathway. Interaction between BrDU-labelled mtDNA and TFAM (A) and BrDU-labelled mtDNA and ZBP1 (B) in control and GOx-treated cells at 1 h. (C) Interaction between ZBP1/TBK1, IRF3/TBK1, ZBP1/P-Tyr and ZBP1/P-Ser in control and GOx-treated cells at 1 h. (D) Interaction between IRF3/TBK1 in pre-treated with 3 μM of CsA in GOx-treated BEAS 2B cells. (E) Level of ZBP1 depletion, shown by Western blotting. (F) Expression of IL-6 and IL-8 in unstressed and GOx-treated (0.006 U/ml for 1 h) in control and ZBP1-depleted BEAS2B cells. Representative images of n = 3 independent experiments are shown. Data represent average ± SEM of n = 5 biological replicates. *p < 0.05 vs. control.
Fig 2: Inflammation respond to mitochondrial DNA in vivo. (A) Inflammatory response triggered in BALF of naïve mice at 24 h post intratracheal administration of 1 μg of isolated mtDNA. (B) Time-dependent expression of IL-1α in BEAS 2B cells incubated 100 ng of isolated mtDNA. (C) Model of inflammation induced by mtDNA/ZBP1 pathway. Data represent average ± SEM using n = 6–8 animals or n = 3 for biological replicates per experimental end-point. *p < 0.05, **p < 0.01 vs. control.
Supplier Page from OriGene Technologies for Z DNA binding protein (ZBP1) Human shRNA Lentiviral Particle (Locus ID 81030)